EGFR and neoplasm: The superior tumor-suppression capacity of Doxy@CaCO3-PEG-activated Tet-HER1-CAR-T-cell therapy was further confirmed in NCI-H23-lung-tumor-bearing nude mice (Fig. 4I–K and Fig. S16).